This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nakade, O. Articles by Lau, K.-H.W. Search for Related Content PubMed PubMed Citation Articles by Nakade, O. Articles by Lau, K.-H.W. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PHENYTOIN SODIUM Social Bookmarking                         What's this?

Phenytoin at Micromolar Concentrations is an Osteogenic Agent for Human-mandible-derived Bone Cells in vitro

Departments of Medicine and Biochemistry, Loma Linda University, and Mineral Metabolism Unit (151), Jerry L. Pettis Memorial V.A. Medical Center, 11201 Benton Street, Loma Linda, California 92357, USA, Department of Oral Pathology, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Hokkaido 061-02, Japan

D.J. Baylink

Departments of Medicine and Biochemistry, Loma Linda University, and Mineral Metabolism Unit (151), Jerry L. Pettis Memorial V.A. Medical Center, 11201 Benton Street, Loma Linda, California 92357, USA

K.-H.W. Lau

Departments of Medicine and Biochemistry, Loma Linda University, and Mineral Metabolism Unit (151), Jerry L. Pettis Memorial V.A. Medical Center, 11201 Benton Street, Loma Linda, California 92357, USA

The present study sought to test the hypothesis that phenytoin acts on normal human-mandible-derived bone cells to induce osteogenic effects. To test the effects of phenytoin on bone cell proliferation, we measured [ ³H]-thymidine incorporation into cell DNA during the final four hr of a 24-hour incubation with phenytoin. Phenytoin at micromolar concentrations significantly stimulated the [3H]-thymidine incorporation in a dose-dependent, biphasic, manner with a maximal effect at from 10 to 50 uM. We confirmed the proliferative effect of phenytoin by counting cell number. To evaluate the effects of phenytoin on osteoblastic differentiation, we determined alkaline-phosphatase specific activity and found that phenytoin at micromolar concentrations significantly increased that activity in a dose-dependent manner, with maximal stimulation at approximately 1 µM. To investigate the effects of phenytoin on mature osteoblastic activities, we measured de novo collagen synthesis and osteocalcin secretion. Mitogenic doses of phenytoin significantly increased collagen synthesis and osteocalcin secretion in a dose-dependent, biphasic, manner, with the maximal stimulatory dose at from 5 to 10 uM. In summary, phenytoin at micromolar ranges increased (a) [3H]-thymidine incorporation and cell number, (b) alkaline-phosphatase specific activity, (c) collagen synthesis, and (d) osteocalcin secretion in monolayer cultures of normal human-mandible-derived bone cells. These observations are consistent with the premise that low doses of phenytoin act on human craniofacial bone cells to stimulate cell proliferation, differentiation, and mature osteoblastic activities to stimulate bone formation.

Key Words: phenytoin • mandibular bone cells • osteogenesis • proliferation • differentiation.

Journal of Dental Research, Vol. 74, No. 1, 331-337 (1995)
DOI: 10.1177/00220345950740010801


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. M. Pack, M. J. Morrell, A. Randall, D. J. McMahon, and E. Shane Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy Neurology, April 29, 2008; 70(18): 1586 - 1593. [Abstract] [Full Text] [PDF]

				S. G. CIANCIO Medications' impact on oral health J Am Dent Assoc, October 1, 2004; 135(10): 1440 - 1448. [Abstract] [Full Text] [PDF]

				K. E. Ensrud, T. S. Walczak, T. Blackwell, E. R. Ensrud, P. J. Bowman, and K. L. Stone Antiepileptic drug use increases rates of bone loss in older women: A prospective study Neurology, June 8, 2004; 62(11): 2051 - 2057. [Abstract] [Full Text] [PDF]